Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate
- 1 May 2001
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (10) , 1160-1163
- https://doi.org/10.1016/s0002-9149(01)01486-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Angiogenesis Is Impaired by HypercholesterolemiaCirculation, 2000
- Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and InfarctionNew England Journal of Medicine, 2000
- Mechanisms modifying atherosclerotic disease — from lipids to vascular biologyAtherosclerosis, 1999
- Vascular Endothelial Growth Factor (VEGF) Expression in Human Coronary Atherosclerotic LesionsCirculation, 1998
- The endothelium in atherothrombotic diseasePublished by Wolters Kluwer Health ,1998
- Vascular endothelial growth factor in diabetic retinopathyThe Lancet, 1997
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996
- Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJournal of Molecular Medicine, 1995
- Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina PectorisNew England Journal of Medicine, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994